Document is current

Article History

Received: 8 April 2025

Accepted: 29 May 2025

First Online: 23 June 2025

Declarations

:

: Seong Jin Jo received a grant from Janssen Pharmaceuticals for the current study and reported receiving grants and/or personal fees for lectures or consultation outside of this study from AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Celltrion Healthcare, Daewoong, Eli Lilly and Company, Green Cross Laboratories, Janssen Pharmaceuticals, Kolon Pharma, LEO Pharma, Novartis, Pfizer, Sanofi, UCB, and Yuhan. Jihye An and Youngdoe Kim are full-time employees of Janssen Korea Ltd., and Byung Soo Kim, Dong Hyun Kim, Hee Joo Kim, Chul Hwan Bang, Bong Seok Shin, Joo-Heung Lee, Ju Hee Lee, Sung Eun Chang, Kyung-Eun Jung, Sang Woong Youn, and Chul Jong Park have no conflicts of interest.

: This study was conducted in accordance with the Declaration of Helsinki, Good Clinical Practices, and applicable regulatory requirements. The study protocol and amendments were reviewed and approved by the appropriate ethics committee at each site (committee names and approval reference numbers are provided in Supplementary Material Table ). Patients or their legal representatives provided their written informed consent to participate in the study.